Apitope develops antigen-specific immunotherapies for the treatment of autoimmune diseases.
Business Model:
Revenue: $10M
Employees: 11-50
Address: Agoralaan
City: Diepenbeek
State: limburg
Zip: 3590
Country: BE
Apitope develops antigen-specific immunotherapies for the treatment of autoimmune diseases.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2015 | Series B | $13.4M |
Vesalius Biocapital LRM |
9/2015 | Series B | $0 |
PMV Pharmaceuticals Arthurian Life Sciences Limburgse Reconversie Maatschappij Vesalius Biocapital Partners Wyvern Seed Fund PMV Pharmaceuticals Arthurian Life Sciences Limburgse Reconversie Maatschappij Vesalius Biocapital Partners Wyvern Seed Fund |
10/2008 | Series A | 2 | $12.9M |
Vesalius Biocapital Partners Vinnof Vesalius Biocapital Partners Vinnof |
12/2012 | Grant | - | 1/2013 | Grant | $1.6M | 10/2008 | Series A | $13.2M |
Vesalius Biocapital LRM, NV. University of Hasslet |
9/2015 | Series B | 5 | $13.5M |
Arthurian Life Sciences Limburgse Reconversie Maatschappij PMV Pharmaceuticals Vesalius Biocapital Partners Wyvern Seed Fund Arthurian Life Sciences Limburgse Reconversie Maatschappij PMV Pharmaceuticals Vesalius Biocapital Partners Wyvern Seed Fund |
12/2012 | Grant | - |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|